Ellen M. Beauchamp

1.7k total citations
6 papers, 315 citations indexed

About

Ellen M. Beauchamp is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ellen M. Beauchamp has authored 6 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ellen M. Beauchamp's work include Lung Cancer Treatments and Mutations (2 papers), Cancer therapeutics and mechanisms (1 paper) and Carbon Dioxide Capture Technologies (1 paper). Ellen M. Beauchamp is often cited by papers focused on Lung Cancer Treatments and Mutations (2 papers), Cancer therapeutics and mechanisms (1 paper) and Carbon Dioxide Capture Technologies (1 paper). Ellen M. Beauchamp collaborates with scholars based in United States and Belgium. Ellen M. Beauchamp's co-authors include Peter S. Hammerman, Matthew Meyerson, Kwok‐Kin Wong, Nathanael S. Gray, Qingsong Liu, Chandra Sekhar Pedamallu, Li Tan, Robert I. Haddad, Matthew D. Wilkerson and Andrey Sivachenko and has published in prestigious journals such as Cancer Research, Molecular Cancer Therapeutics and Photosynthesis Research.

In The Last Decade

Ellen M. Beauchamp

6 papers receiving 307 citations

Peers

Countries citing papers authored by Ellen M. Beauchamp

Since Specialization

Citations

This map shows the geographic impact of Ellen M. Beauchamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen M. Beauchamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen M. Beauchamp more than expected).

Fields of papers citing papers by Ellen M. Beauchamp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen M. Beauchamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen M. Beauchamp. The network helps show where Ellen M. Beauchamp may publish in the future.

Co-authorship network of co-authors of Ellen M. Beauchamp

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen M. Beauchamp. A scholar is included among the top collaborators of Ellen M. Beauchamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen M. Beauchamp. Ellen M. Beauchamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Identification and characterization of an alternative cancer-derived PD-L1 splice variant 2018 ·Cancer Immunology Immunotherapy ·Nadia B. Hassounah, Venkat S. Malladi, Yi Huang, Samuel S. Freeman, Ellen M. Beauchamp, Shohei Koyama, Nicholas Souders, Sunil Martin, Glenn Dranoff, Kwok‐Kin Wong, Chandra Sekhar Pedamallu, Peter S. Hammerman, Esra A. Akbay	62
2	NSCLC Driven by DDR2 Mutation Is Sensitive to Dasatinib and JQ1 Combination Therapy 2015 ·Molecular Cancer Therapeutics ·Chunxiao Xu, Kevin A. Buczkowski, (unknown), Hajime Asahina, Ellen M. Beauchamp, Hideki Terai, Yvonne Y. Li, Matthew Meyerson, Kwok‐Kin Wong, Peter S. Hammerman	24
3	Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer 2015 ·ACS Chemical Biology ·Hideki Terai, Li Tan, Ellen M. Beauchamp, John M. Hatcher, Qingsong Liu, Matthew Meyerson, Nathanael S. Gray, Peter S. Hammerman	43
4	The Prochlorococcus carbon dioxide-concentrating mechanism: evidence of carboxysome-associated heterogeneity 2014 ·Photosynthesis Research ·Claire S. Ting, (unknown), (unknown), (unknown), (unknown), (unknown), Ellen M. Beauchamp	8
5	Acquired Resistance to Dasatinib in Lung Cancer Cell Lines Conferred by DDR2 Gatekeeper Mutation and NF1 Loss 2013 ·Molecular Cancer Therapeutics ·Ellen M. Beauchamp, Brittany A. Woods, Austin Dulak, Li Tan, Chunxiao Xu, Nathanael S. Gray, Adam J. Bass, Kwok‐Kin Wong, Matthew Meyerson, Peter S. Hammerman	44
6	Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma 2013 ·Cancer Research ·Rachel G. Liao, Joonil Jung, Jeremy H. Tchaicha, Matthew D. Wilkerson, Andrey Sivachenko, Ellen M. Beauchamp, Qingsong Liu, Trevor J. Pugh, Chandra Sekhar Pedamallu, D. Neil Hayes, Nathanael S. Gray, Gad Getz, Kwok‐Kin Wong, Robert I. Haddad, Matthew Meyerson, Peter S. Hammerman	134

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact